Literature DB >> 27490940

Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene.

Xue Xiao1, Cybele Ghossein2, Agustín Tortajada3, Yuzhou Zhang4, Nicole Meyer4, Michael Jones4, Nicolo Ghiringhelli Borsa4, Carla M Nester5, Christie P Thomas6, Santiago Rodríquez de Córdoba3, Richard J H Smith7.   

Abstract

C3 glomerulopathy (C3G) is an ultra-rare complement-mediated renal disease characterized histologically by the predominance of C3 deposition within in the glomerulus. Familial cases of C3G are extremely uncommon and offer unique insight into the genetic drivers of complement dysregulation. In this report, we describe a patient who presented with C3G. Because a relative carried the same diagnosis, we sought an underlying genetic commonality to explain the phenotype. As part of a comprehension genetic screen, we completed multiplex ligation-dependent probe amplification across the complement factor H related region and identified amplification alterations consistent with a genomic rearrangement. Using comparative genomic hybridization, we narrowed and then cloned the rearrangement breakpoints thereby defining a novel fusion gene that is translated into a serum protein comprised of factor H related-5 (short consensus repeats 1 and 2) and factor H-related-2 (short consensus repeats 1-4). These data highlight the role of factor H related proteins in the control of complement activity and illustrate how perturbation of that control leads to C3G.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  C3 glomerulopathy; Complement factor H related-2; Complement factor H related-5

Mesh:

Substances:

Year:  2016        PMID: 27490940     DOI: 10.1016/j.molimm.2016.07.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  25 in total

Review 1.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

2.  Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA.

Authors:  Jesús García-Fernández; Susana Vilches-Arroyo; Leticia Olavarrieta; Julián Pérez-Pérez; Santiago Rodríguez de Córdoba
Journal:  Methods Mol Biol       Date:  2021

3.  C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.

Authors:  Yuzhou Zhang; Nicole C Meyer; Fernando C Fervenza; Winnie Lau; Adam Keenan; Gabriel Cara-Fuentes; Dingwu Shao; Aalia Akber; Veronique Fremeaux-Bacchi; Sanjeev Sethi; Carla M Nester; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2017-08-24       Impact factor: 8.860

4.  Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Authors:  Paraskevas Iatropoulos; Erica Daina; Manuela Curreri; Rossella Piras; Elisabetta Valoti; Caterina Mele; Elena Bresin; Sara Gamba; Marta Alberti; Matteo Breno; Annalisa Perna; Serena Bettoni; Ettore Sabadini; Luisa Murer; Marina Vivarelli; Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

Review 5.  C3 glomerulopathy - understanding a rare complement-driven renal disease.

Authors:  Richard J H Smith; Gerald B Appel; Anna M Blom; H Terence Cook; Vivette D D'Agati; Fadi Fakhouri; Véronique Fremeaux-Bacchi; Mihály Józsi; David Kavanagh; John D Lambris; Marina Noris; Matthew C Pickering; Giuseppe Remuzzi; Santiago Rodriguez de Córdoba; Sanjeev Sethi; Johan Van der Vlag; Peter F Zipfel; Carla M Nester
Journal:  Nat Rev Nephrol       Date:  2019-03       Impact factor: 28.314

6.  Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.

Authors:  Adam P Levine; Melanie M Y Chan; Omid Sadeghi-Alavijeh; Edwin K S Wong; H Terence Cook; Sofie Ashford; Keren Carss; Martin T Christian; Matthew Hall; Claire Louise Harris; Paul McAlinden; Kevin J Marchbank; Stephen D Marks; Heather Maxwell; Karyn Megy; Christopher J Penkett; Monika Mozere; Kathleen E Stirrups; Salih Tuna; Julie Wessels; Deborah Whitehorn; Sally A Johnson; Daniel P Gale
Journal:  J Am Soc Nephrol       Date:  2020-01-09       Impact factor: 10.121

7.  The Benefits of Complement Measurements for the Clinical Practice.

Authors:  Anne Grunenwald; Lubka T Roumenina
Journal:  Methods Mol Biol       Date:  2021

Review 8.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

9.  Clinicopathological features of C3 glomerulopathy in children: a single-center experience.

Authors:  Keri A Drake; Natalie Ellington; Jyothsna Gattineni; Jose R Torrealba; Allen R Hendricks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

10.  Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.

Authors:  Yuzhou Zhang; Robin A Kremsdorf; C John Sperati; Kammi J Henriksen; Mari Mori; Renee X Goodfellow; Gabriella R Pitcher; Cindy L Benson; Nicolo Ghiringhelli Borsa; Ronald P Taylor; Carla M Nester; Richard J H Smith
Journal:  Kidney Int       Date:  2020-06-12       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.